ABX203 Therapeutic Vaccine

· Abivax S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABX203 Therapeutic Vaccine, covering 2017-01-24 to 2017-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B [Phase 2, Phase 3]

See pricing